Truist Securities Maintains Buy on Option Care Health, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Option Care Health but lowered the price target from $41 to $34.

November 01, 2024 | 10:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a Buy rating on Option Care Health but lowered the price target from $41 to $34.
The maintenance of a Buy rating suggests continued confidence in the stock's potential, but the lowered price target indicates a more cautious outlook on its valuation. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100